Fortune has published a feature article about BERG and the announcement of our Phase II trials in pancreatic cancer. The article will be published in the May edition of Fortune magazine. You can view the online version of the story here: Fortune: This Company Wants to Cure Pancreatic Cancer Using AI

The Mendelspod podcast talked to BERG’s CEO Niven R. Narain to discuss how BERG is flipping drug development upside down by examining patient biology with the help of AI. You can listen to the podcast here: Flipping Drug Development Upside Down: Niven Narain, BERG Health

  Wired UK has published a feature article profiling BERG and our CEO NIven R. Narain. The article will be in the April edition of WIRED UK. You can view the online article here: “The Startup Fighting Cancer with AI”  

Bloomberg Radio – Taking Stock talks to BERG’s Co-Founder and CEO about precision medicine and our lead cancer therapeutic candidate BPM31510. You can listen to the story at our Youtube channel via this link: https://youtu.be/rwne_r1JpYU

The Bloomberg Advantage with Carol Massar and Cory Johnson sit down with Niven Narain Co-Founder and Chief Technology Officer of BERG to discuss the potential of artificial intelligence for everything from working to cure diseases to providing recommendations on business decisions. Click here to listen to the story: Bloomberg Advantage

Biopharma Dive – The year Ahead: 11 Execs & Experts predict what’s in store for biopharma in 2016. BERG’s VP of systems medicine, Michael Kiebish offers his predictions and insight. Click here to read the full article: Biopharma Dive